Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

He reached out to two biotech companies to see if they had any open roles, only to learn they had either paused or delayed any hiring as they waited to learn the fate of their NIH grants.

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...

April saw quite a bit of movement in the biotech C-Suites, including both departures and arrivals. Read on for a whirlwind, worldwide tour of recent personnel moves. Sanofi bids to add a drug ...

Teva is al Teva Pharmaceutical Industries (NYSE:TEVA) recently made headlines by upsizing its senior notes offering to approximately $2.3 billion, aimed at managing its debt obligations.

Roche’s recent spate of billion-dollar plus alliances has continued with a deal with UK biotech Bicycle Therapeutics – worth up to $1.7 billion – in the area of cancer immunotherapy.

As global markets navigate a landscape marked by trade negotiations and economic uncertainty, Asia's financial scene remains a focal point for investors seeking opportunities amid evolving conditions.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, HANSIZHUANG, or serplulimab, has been approved by the European Commission to ...